Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer.
Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...
– Dose expansion ongoing in TNG908 and TNG462 phase 1/2 clinical trials; comprehensive clinical data update for the PRMT5 program expected in 2H 2024 – – Patient enrollment is ongoing in TNG260...
Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced that...
Medivir´s licensee, Tango Therapeutics, has discontinued development of its TNG348 clinical program PR Newswire STOCKHOLM, May 23, 2024 STOCKHOLM, May 23, 2024 /PRNewswire/ -- Medivir AB (Nasdaq...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.02 | -11.9858989424 | 8.51 | 8.67 | 7.335 | 1233613 | 7.97723503 | CS |
4 | -3.91 | -34.298245614 | 11.4 | 11.92 | 7.335 | 1332688 | 9.26377105 | CS |
12 | -0.82 | -9.86762936221 | 8.31 | 12.015 | 7.335 | 914515 | 9.53213755 | CS |
26 | -0.19 | -2.47395833333 | 7.68 | 12.015 | 6.46 | 757450 | 8.83373338 | CS |
52 | -3.52 | -31.9709355132 | 11.01 | 13.03 | 5.15 | 837966 | 9.13245966 | CS |
156 | -5.93 | -44.1877794337 | 13.42 | 14.96 | 2.47 | 567655 | 8.07037064 | CS |
260 | -2.12 | -22.0603537981 | 9.61 | 18.84 | 2.47 | 556690 | 8.22537732 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales